Heerspink, H. J., Stefánsson, B. V., Correa-Rotter, R., Chertow, G. M., Greene, T., Hou, F., . . . Wheeler, D. C. (2020). Dapagliflozin in Patients with Chronic Kidney Disease. The New England journal of medicine, 383(15), 1436-1446. https://doi.org/10.1056/NEJMoa2024816
Citace podle Chicago (17th ed.)Heerspink, Hiddo J.L, et al. "Dapagliflozin in Patients with Chronic Kidney Disease." The New England Journal of Medicine 383, no. 15 (2020): 1436-1446. https://doi.org/10.1056/NEJMoa2024816.
Citace podle MLA (9th ed.)Heerspink, Hiddo J.L, et al. "Dapagliflozin in Patients with Chronic Kidney Disease." The New England Journal of Medicine, vol. 383, no. 15, 2020, pp. 1436-1446, https://doi.org/10.1056/NEJMoa2024816.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..